Zobrazeno 1 - 7
of 7
pro vyhledávání: '"María Laura Albert"'
Autor:
María Laura Albert, Cristina Borrajo, Carlos A. Jiménez-Ruiz, Juan Antonio Riesco Miranda, Agustín Acuña Izcaray, Gustavo Zabert, Susana Luhning, Fabian Caro, José Ignacio de Granda-Orive, José Antonio Rodríguez Portal, Ivette Buendia, Daniel Buljubasich, Efrain Sanchez Angarita
Publikováno v:
Archivos de Bronconeumología. 56:435-440
Introduction The Smoking and the Diffuse Interstitial Lung Diseases (ILD) groups of ALAT and SEPAR collaborated in the preparation of this document. Materials and methods This document uses PICO methodology to answer various questions on the relation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1e62dd6d3099478d0d41bccef05c62b
https://doi.org/10.1016/j.arbres.2019.09.022
https://doi.org/10.1016/j.arbres.2019.09.022
Autor:
Carlos A. Jiménez-Ruiz, Gustavo Zabert, Daniel Buljubasich, Jose Ignacio de Granda-Orive, Ivette Buendía, Susana Luhning, Jose Antonio Rodriguez Portal, Fabian Caro, María Laura Albert, Juan Antonio Riesco Miranda, Cristina Borrajo, Efrain Sánchez Angarita, Agustín Acuña Izcaray
Publikováno v:
Archivos de bronconeumologia. 56(7)
The Smoking and the Diffuse Interstitial Lung Diseases (ILD) groups of ALAT and SEPAR collaborated in the preparation of this document.This document uses PICO methodology to answer various questions on the relationship between tobacco use and diffuse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757d4588f4aa1f4e5b95c881dcfecd89
https://pubmed.ncbi.nlm.nih.gov/31753676
https://pubmed.ncbi.nlm.nih.gov/31753676
Autor:
Francisco Paulin, Natalia Zamora, Dora Lombardi, Fernando Erra Díaz, Matías Perli, Ana Lizarraga, Martín Fernández, María Laura Alberti, Fabián Caro, Leandro Fassola, Jorge Geffner
Publikováno v:
Revista Argentina de Reumatología, Vol 33, Iss 4 (2022)
Introducción: el objetivo de este estudio fue analizar la relación entre los valores de IL13 y su pronóstico en pacientes con artritis reumatoidea (AR) y enfermedad pulmonar intersticial (EPI). Materiales y métodos: estudio de cohorte prospect
Externí odkaz:
https://doaj.org/article/c5e332fb576a45baa0fcd8a20f84dfa2
Autor:
Francisco Paulin, Anastasia Secco, Federico Benavidez, Juan José Rodríguez Moncalvo, Orlando Gabriel Carballo, Fernanda Ingenito, Martin Eduardo Fernández, Agustina Cáceres, Fabian Caro, Patricia Sasaki, María Laura Alberti, Paola Orausclio, Augusto Riopedre, Santiago Rossi, María Celina de la Vega
Publikováno v:
Advances in Rheumatology, Vol 61, Iss 1, Pp 1-7 (2021)
Abstract Background Clinically evident interstitial lung disease (ILD) affects between 10 and 42% of the patients with rheumatoid arthritis (RA). Airway involvement seems to be even more common. Most of the available evidence comes from studies perfo
Externí odkaz:
https://doaj.org/article/bd745de500194d608d8e2fe83c465cb0
Autor:
Maria Laura Alberti, Jose María Malet Ruiz, Martin Eduardo Fernández, Leandro Fassola, Fabián Caro, Ivette Buendía Roldán, Francisco Paulin
Publikováno v:
Pulmonology, Vol 26, Iss 1, Pp 3-9 (2020)
Introduction: Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differenti
Externí odkaz:
https://doaj.org/article/35f48bb12cfc4d3fa28464bb73ffea04
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Hypersensitivity pneumonitis (HP) is one of the most common interstitial lung diseases (ILD), that presents unique challenges for a confident diagnosis and limited therapeutic options. The disease is triggered by exposure to a wide variety of incitin
Externí odkaz:
https://doaj.org/article/ec49eacbeaca4b03bcdcda968aee3389
Autor:
Mauricio Gonzalez-Garcia, Emily Rincon-Alvarez, Maria Laura Alberti, Mauricio Duran, Fabian Caro, Maria del Carmen Venero, Yuri Edison Liberato, Ivette Buendia-Roldan
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Comorbidities in idiopathic pulmonary fibrosis (IPF) affect quality of life, symptoms, disease progression and survival. It is unknown what are the comorbidities in patients with IPF in Latin America (LA) and if there are differences betw
Externí odkaz:
https://doaj.org/article/6ec979ee50854b63b52897b6b175dbcd